Lv11
30 积分 2021-10-27 加入
Liquid Biopsy: From Discovery to Clinical Application
2小时前
待确认
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
2年前
已完结
结节性淋巴细胞为主型霍奇金淋巴瘤向富含T细胞/组织细胞的大B细胞淋巴瘤样转化一例并文献复习
2年前
已完结
A Phase I/II Study to Examine the Safety and Efficacy of Pembrolizumab 200 Mg Fixed Dose Administered Every 3 Weeks (Q3W) in Combination with Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
2年前
已关闭
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial
3年前
已完结
皖公网安备34019202002308
